SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '4r39'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1AJ6_A_NOVA1_1 (GYRASE)	4r39	BLUE-LIGHT-ACTIVATED HISTIDINE KINASE 2 (Erythrobacter litoralis)	5 / 9	ASN A 250 ASP A 282 ILE A 287 PRO A 288 THR A 324	MG A 401 ( 2.4A) ANP A 402 (-2.7A) ANP A 402 (-4.3A) ANP A 402 ( 4.4A) ANP A 402 (-3.6A)	0.92A	1aj6A-4r39A: 4.1	1aj6A-4r39A: 22.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1AJ6_A_NOVA1_1 (GYRASE)	4r39	BLUE-LIGHT-ACTIVATED HISTIDINE KINASE 2 (Erythrobacter litoralis)	5 / 9	ASP A 282 ARG A 285 ILE A 287 PRO A 288 THR A 324	ANP A 402 (-2.7A) None ANP A 402 (-4.3A) ANP A 402 ( 4.4A) ANP A 402 (-3.6A)	1.24A	1aj6A-4r39A: 4.1	1aj6A-4r39A: 22.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1HK2_A_T44A3002_1 (SERUM ALBUMIN)	4r39	BLUE-LIGHT-ACTIVATED HISTIDINE KINASE 2 (Erythrobacter litoralis)	4 / 8	GLN A 335 LEU A 276 LEU A 205 TYR A 204	None	1.19A	1hk2A-4r39A: undetectable	1hk2A-4r39A: 16.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1KIJ_A_NOVA400_1 (DNA GYRASE SUBUNIT B)	4r39	BLUE-LIGHT-ACTIVATED HISTIDINE KINASE 2 (Erythrobacter litoralis)	5 / 12	ARG A 285 ILE A 287 PRO A 288 ASP A 290 THR A 324	None ANP A 402 (-4.3A) ANP A 402 ( 4.4A) None ANP A 402 (-3.6A)	1.30A	1kijA-4r39A: 4.0	1kijA-4r39A: 20.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1KIJ_A_NOVA400_1 (DNA GYRASE SUBUNIT B)	4r39	BLUE-LIGHT-ACTIVATED HISTIDINE KINASE 2 (Erythrobacter litoralis)	5 / 12	ASP A 282 ILE A 287 PRO A 288 ASP A 290 THR A 324	ANP A 402 (-2.7A) ANP A 402 (-4.3A) ANP A 402 ( 4.4A) None ANP A 402 (-3.6A)	0.99A	1kijA-4r39A: 4.0	1kijA-4r39A: 20.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1KIJ_B_NOVB444_1 (DNA GYRASE SUBUNIT B)	4r39	BLUE-LIGHT-ACTIVATED HISTIDINE KINASE 2 (Erythrobacter litoralis)	5 / 12	ASN A 250 ARG A 285 ILE A 287 PRO A 288 THR A 324	MG A 401 ( 2.4A) None ANP A 402 (-4.3A) ANP A 402 ( 4.4A) ANP A 402 (-3.6A)	1.19A	1kijB-4r39A: 4.6	1kijB-4r39A: 20.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1KIJ_B_NOVB444_1 (DNA GYRASE SUBUNIT B)	4r39	BLUE-LIGHT-ACTIVATED HISTIDINE KINASE 2 (Erythrobacter litoralis)	5 / 12	ASN A 250 ASP A 282 ILE A 287 PRO A 288 THR A 324	MG A 401 ( 2.4A) ANP A 402 (-2.7A) ANP A 402 (-4.3A) ANP A 402 ( 4.4A) ANP A 402 (-3.6A)	0.95A	1kijB-4r39A: 4.6	1kijB-4r39A: 20.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1KIJ_B_NOVB444_1 (DNA GYRASE SUBUNIT B)	4r39	BLUE-LIGHT-ACTIVATED HISTIDINE KINASE 2 (Erythrobacter litoralis)	5 / 12	ASP A 282 ILE A 287 PRO A 288 ASP A 290 THR A 324	ANP A 402 (-2.7A) ANP A 402 (-4.3A) ANP A 402 ( 4.4A) None ANP A 402 (-3.6A)	1.00A	1kijB-4r39A: 4.6	1kijB-4r39A: 20.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1MRQ_A_STRA501_1 (ALDO-KETO REDUCTASE FAMILY 1 MEMBER C1)	4r39	BLUE-LIGHT-ACTIVATED HISTIDINE KINASE 2 (Erythrobacter litoralis)	5 / 11	TYR A 204 VAL A 278 ILE A 328 LEU A 148 LEU A 307	None	1.14A	1mrqA-4r39A: undetectable	1mrqA-4r39A: 21.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2X45_A_HSMA1161_1 (ALLERGEN ARG R 1)	4r39	BLUE-LIGHT-ACTIVATED HISTIDINE KINASE 2 (Erythrobacter litoralis)	4 / 5	VAL A 232 VAL A 270 ASP A 228 SER A 268	None	1.18A	2x45A-4r39A: undetectable	2x45A-4r39A: 17.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3LPS_A_NOVA901_1 (TOPOISOMERASE IV SUBUNIT B)	4r39	BLUE-LIGHT-ACTIVATED HISTIDINE KINASE 2 (Erythrobacter litoralis)	6 / 12	ASN A 250 ASP A 282 ARG A 285 PRO A 288 ASP A 290 THR A 324	MG A 401 ( 2.4A) ANP A 402 (-2.7A) None ANP A 402 ( 4.4A) None ANP A 402 (-3.6A)	1.30A	3lpsA-4r39A: 3.6	3lpsA-4r39A: 20.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3TQ9_A_MTXA2001_1 (DIHYDROFOLATE REDUCTASE)	4r39	BLUE-LIGHT-ACTIVATED HISTIDINE KINASE 2 (Erythrobacter litoralis)	5 / 12	ILE A 339 LEU A 182 LEU A 148 ILE A 240 LEU A 311	None	0.98A	3tq9A-4r39A: undetectable	3tq9A-4r39A: 20.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3VN2_A_TLSA501_1 (PEROXISOME PROLIFERATOR-ACTIVAT ED RECEPTOR GAMMA)	4r39	BLUE-LIGHT-ACTIVATED HISTIDINE KINASE 2 (Erythrobacter litoralis)	5 / 12	SER A 245 ILE A 208 TYR A 204 LEU A 205 LEU A 311	None	1.25A	3vn2A-4r39A: undetectable	3vn2A-4r39A: 24.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4F4D_B_CHDB503_0 (FERROCHELATASE, MITOCHONDRIAL)	4r39	BLUE-LIGHT-ACTIVATED HISTIDINE KINASE 2 (Erythrobacter litoralis)	4 / 8	ILE A 151 ARG A 175 PRO A 294 TRP A 293	None ANP A 402 (-3.8A) None ANP A 402 (-4.4A)	1.26A	4f4dB-4r39A: undetectable	4f4dB-4r39A: 21.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4L1X_A_STRA402_1 (ALDO-KETO REDUCTASE FAMILY 1 MEMBER C2)	4r39	BLUE-LIGHT-ACTIVATED HISTIDINE KINASE 2 (Erythrobacter litoralis)	4 / 8	TYR A 204 VAL A 278 LEU A 148 LEU A 307	None	1.02A	4l1xA-4r39A: undetectable	4l1xA-4r39A: 22.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4L1X_B_STRB402_1 (ALDO-KETO REDUCTASE FAMILY 1 MEMBER C2)	4r39	BLUE-LIGHT-ACTIVATED HISTIDINE KINASE 2 (Erythrobacter litoralis)	5 / 9	TYR A 204 VAL A 278 ILE A 328 LEU A 148 LEU A 307	None	1.16A	4l1xB-4r39A: undetectable	4l1xB-4r39A: 22.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4URO_C_NOVC2000_1 (DNA GYRASE SUBUNIT B)	4r39	BLUE-LIGHT-ACTIVATED HISTIDINE KINASE 2 (Erythrobacter litoralis)	5 / 12	ASP A 282 ARG A 285 ILE A 287 PRO A 288 ASP A 290	ANP A 402 (-2.7A) None ANP A 402 (-4.3A) ANP A 402 ( 4.4A) None	1.29A	4uroC-4r39A: 4.1	4uroC-4r39A: 26.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4URO_D_NOVD2000_1 (DNA GYRASE SUBUNIT B)	4r39	BLUE-LIGHT-ACTIVATED HISTIDINE KINASE 2 (Erythrobacter litoralis)	5 / 12	ARG A 285 ILE A 287 PRO A 288 ASP A 290 THR A 324	None ANP A 402 (-4.3A) ANP A 402 ( 4.4A) None ANP A 402 (-3.6A)	1.17A	4uroD-4r39A: 5.3	4uroD-4r39A: 26.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4URO_D_NOVD2000_1 (DNA GYRASE SUBUNIT B)	4r39	BLUE-LIGHT-ACTIVATED HISTIDINE KINASE 2 (Erythrobacter litoralis)	5 / 12	ASN A 250 ARG A 285 ILE A 287 PRO A 288 THR A 324	MG A 401 ( 2.4A) None ANP A 402 (-4.3A) ANP A 402 ( 4.4A) ANP A 402 (-3.6A)	1.13A	4uroD-4r39A: 5.3	4uroD-4r39A: 26.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4URO_D_NOVD2000_1 (DNA GYRASE SUBUNIT B)	4r39	BLUE-LIGHT-ACTIVATED HISTIDINE KINASE 2 (Erythrobacter litoralis)	5 / 12	ASN A 250 ASP A 282 ILE A 287 PRO A 288 THR A 324	MG A 401 ( 2.4A) ANP A 402 (-2.7A) ANP A 402 (-4.3A) ANP A 402 ( 4.4A) ANP A 402 (-3.6A)	0.90A	4uroD-4r39A: 5.3	4uroD-4r39A: 26.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4URO_D_NOVD2000_1 (DNA GYRASE SUBUNIT B)	4r39	BLUE-LIGHT-ACTIVATED HISTIDINE KINASE 2 (Erythrobacter litoralis)	5 / 12	ASP A 282 ILE A 287 PRO A 288 ASP A 290 THR A 324	ANP A 402 (-2.7A) ANP A 402 (-4.3A) ANP A 402 ( 4.4A) None ANP A 402 (-3.6A)	0.88A	4uroD-4r39A: 5.3	4uroD-4r39A: 26.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4YVP_B_GBMB402_1 (ALDO-KETO REDUCTASE FAMILY 1 MEMBER C1)	4r39	BLUE-LIGHT-ACTIVATED HISTIDINE KINASE 2 (Erythrobacter litoralis)	5 / 12	TYR A 204 VAL A 278 ILE A 328 LEU A 148 LEU A 307	None	1.08A	4yvpB-4r39A: undetectable	4yvpB-4r39A: 21.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5DPD_A_SAMA601_0 (PROTEIN LYSINE METHYLTRANSFERASE 1)	4r39	BLUE-LIGHT-ACTIVATED HISTIDINE KINASE 2 (Erythrobacter litoralis)	5 / 12	LEU A 332 SER A 333 GLN A 334 ILE A 240 VAL A 278	None	1.04A	5dpdA-4r39A: undetectable	5dpdA-4r39A: 17.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5DPD_B_SAMB601_0 (PROTEIN LYSINE METHYLTRANSFERASE 1)	4r39	BLUE-LIGHT-ACTIVATED HISTIDINE KINASE 2 (Erythrobacter litoralis)	5 / 12	LEU A 332 SER A 333 GLN A 334 ILE A 240 VAL A 278	None	1.17A	5dpdB-4r39A: undetectable	5dpdB-4r39A: 17.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6DJZ_C_GMJC301_0 (SIGMA NON-OPIOID INTRACELLULAR RECEPTOR 1)	4r39	BLUE-LIGHT-ACTIVATED HISTIDINE KINASE 2 (Erythrobacter litoralis)	5 / 12	LEU A 266 VAL A 308 THR A 249 LEU A 252 ALA A 251	None None None None ANP A 402 ( 4.1A)	1.15A	6djzC-4r39A: undetectable	6djzC-4r39A: 24.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6DLZ_A_CYZA1302_0 (GLUTAMATE RECEPTOR 2,VOLTAGE-DEPENDENT CALCIUM CHANNEL GAMMA-2 SUBUNIT)	4r39	BLUE-LIGHT-ACTIVATED HISTIDINE KINASE 2 (Erythrobacter litoralis)	5 / 10	LEU A 242 SER A 245 ASP A 216 ILE A 303 GLY A 300	None None None None ANP A 402 (-3.3A)	1.46A	6dlzA-4r39A: undetectable 6dlzD-4r39A: undetectable	6dlzA-4r39A: 17.04 6dlzD-4r39A: 17.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6DLZ_C_CYZC1302_0 (GLUTAMATE RECEPTOR 2,VOLTAGE-DEPENDENT CALCIUM CHANNEL GAMMA-2 SUBUNIT)	4r39	BLUE-LIGHT-ACTIVATED HISTIDINE KINASE 2 (Erythrobacter litoralis)	5 / 10	ILE A 303 GLY A 300 LEU A 242 SER A 245 ASP A 216	None ANP A 402 (-3.3A) None None None	1.46A	6dlzB-4r39A: undetectable 6dlzC-4r39A: undetectable	6dlzB-4r39A: 17.04 6dlzC-4r39A: 17.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6DM1_A_CYZA1302_0 (GLUTAMATE RECEPTOR 2,VOLTAGE-DEPENDENT CALCIUM CHANNEL GAMMA-2 SUBUNIT)	4r39	BLUE-LIGHT-ACTIVATED HISTIDINE KINASE 2 (Erythrobacter litoralis)	5 / 10	LEU A 242 SER A 245 ASP A 216 ILE A 303 GLY A 300	None None None None ANP A 402 (-3.3A)	1.46A	6dm1A-4r39A: undetectable 6dm1D-4r39A: undetectable	6dm1A-4r39A: 17.04 6dm1D-4r39A: 17.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6DM1_C_CYZC1302_0 (GLUTAMATE RECEPTOR 2,VOLTAGE-DEPENDENT CALCIUM CHANNEL GAMMA-2 SUBUNIT)	4r39	BLUE-LIGHT-ACTIVATED HISTIDINE KINASE 2 (Erythrobacter litoralis)	5 / 10	ILE A 303 GLY A 300 LEU A 242 SER A 245 ASP A 216	None ANP A 402 (-3.3A) None None None	1.47A	6dm1B-4r39A: undetectable 6dm1C-4r39A: undetectable	6dm1B-4r39A: 17.04 6dm1C-4r39A: 17.04

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1AJ6_A_NOVA1_1","GYRASE","4r39","BLUE-LIGHT-ACTIVATED HISTIDINE KINASE 2","Erythrobacter litoralis",5,"ASN A 250;ASP A 282;ILE A 287;PRO A 288;THR A 324"," MG A 401 ( 2.4A);ANP A 402 (-2.7A);ANP A 402 (-4.3A);ANP A 402 ( 4.4A);ANP A 402 (-3.6A)","0.92A","1aj6A-4r39A:4.1","1aj6A-4r39A:22.14"],["1AJ6_A_NOVA1_1","GYRASE","4r39","BLUE-LIGHT-ACTIVATED HISTIDINE KINASE 2","Erythrobacter litoralis",5,"ASP A 282;ARG A 285;ILE A 287;PRO A 288;THR A 324","ANP A 402 (-2.7A);None;ANP A 402 (-4.3A);ANP A 402 ( 4.4A);ANP A 402 (-3.6A)","1.24A","1aj6A-4r39A:4.1","1aj6A-4r39A:22.14"],["1HK2_A_T44A3002_1","SERUM ALBUMIN","4r39","BLUE-LIGHT-ACTIVATED HISTIDINE KINASE 2","Erythrobacter litoralis",4,"GLN A 335;LEU A 276;LEU A 205;TYR A 204","None","1.19A","1hk2A-4r39A:undetectable","1hk2A-4r39A:16.70"],["1KIJ_A_NOVA400_1","DNA GYRASE SUBUNIT B","4r39","BLUE-LIGHT-ACTIVATED HISTIDINE KINASE 2","Erythrobacter litoralis",5,"ARG A 285;ILE A 287;PRO A 288;ASP A 290;THR A 324","None;ANP A 402 (-4.3A);ANP A 402 ( 4.4A);None;ANP A 402 (-3.6A)","1.30A","1kijA-4r39A:4.0","1kijA-4r39A:20.91"],["1KIJ_A_NOVA400_1","DNA GYRASE SUBUNIT B","4r39","BLUE-LIGHT-ACTIVATED HISTIDINE KINASE 2","Erythrobacter litoralis",5,"ASP A 282;ILE A 287;PRO A 288;ASP A 290;THR A 324","ANP A 402 (-2.7A);ANP A 402 (-4.3A);ANP A 402 ( 4.4A);None;ANP A 402 (-3.6A)","0.99A","1kijA-4r39A:4.0","1kijA-4r39A:20.91"],["1KIJ_B_NOVB444_1","DNA GYRASE SUBUNIT B","4r39","BLUE-LIGHT-ACTIVATED HISTIDINE KINASE 2","Erythrobacter litoralis",5,"ASN A 250;ARG A 285;ILE A 287;PRO A 288;THR A 324"," MG A 401 ( 2.4A);None;ANP A 402 (-4.3A);ANP A 402 ( 4.4A);ANP A 402 (-3.6A)","1.19A","1kijB-4r39A:4.6","1kijB-4r39A:20.91"],["1KIJ_B_NOVB444_1","DNA GYRASE SUBUNIT B","4r39","BLUE-LIGHT-ACTIVATED HISTIDINE KINASE 2","Erythrobacter litoralis",5,"ASN A 250;ASP A 282;ILE A 287;PRO A 288;THR A 324"," MG A 401 ( 2.4A);ANP A 402 (-2.7A);ANP A 402 (-4.3A);ANP A 402 ( 4.4A);ANP A 402 (-3.6A)","0.95A","1kijB-4r39A:4.6","1kijB-4r39A:20.91"],["1KIJ_B_NOVB444_1","DNA GYRASE SUBUNIT B","4r39","BLUE-LIGHT-ACTIVATED HISTIDINE KINASE 2","Erythrobacter litoralis",5,"ASP A 282;ILE A 287;PRO A 288;ASP A 290;THR A 324","ANP A 402 (-2.7A);ANP A 402 (-4.3A);ANP A 402 ( 4.4A);None;ANP A 402 (-3.6A)","1.00A","1kijB-4r39A:4.6","1kijB-4r39A:20.91"],["1MRQ_A_STRA501_1","ALDO-KETO REDUCTASE FAMILY 1 MEMBER C1","4r39","BLUE-LIGHT-ACTIVATED HISTIDINE KINASE 2","Erythrobacter litoralis",5,"TYR A 204;VAL A 278;ILE A 328;LEU A 148;LEU A 307","None","1.14A","1mrqA-4r39A:undetectable","1mrqA-4r39A:21.85"],["2X45_A_HSMA1161_1","ALLERGEN ARG R 1","4r39","BLUE-LIGHT-ACTIVATED HISTIDINE KINASE 2","Erythrobacter litoralis",4,"VAL A 232;VAL A 270;ASP A 228;SER A 268","None","1.18A","2x45A-4r39A:undetectable","2x45A-4r39A:17.80"],["3LPS_A_NOVA901_1","TOPOISOMERASE IV SUBUNIT B","4r39","BLUE-LIGHT-ACTIVATED HISTIDINE KINASE 2","Erythrobacter litoralis",6,"ASN A 250;ASP A 282;ARG A 285;PRO A 288;ASP A 290;THR A 324"," MG A 401 ( 2.4A);ANP A 402 (-2.7A);None;ANP A 402 ( 4.4A);None;ANP A 402 (-3.6A)","1.30A","3lpsA-4r39A:3.6","3lpsA-4r39A:20.39"],["3TQ9_A_MTXA2001_1","DIHYDROFOLATE REDUCTASE","4r39","BLUE-LIGHT-ACTIVATED HISTIDINE KINASE 2","Erythrobacter litoralis",5,"ILE A 339;LEU A 182;LEU A 148;ILE A 240;LEU A 311","None","0.98A","3tq9A-4r39A:undetectable","3tq9A-4r39A:20.73"],["3VN2_A_TLSA501_1","PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA","4r39","BLUE-LIGHT-ACTIVATED HISTIDINE KINASE 2","Erythrobacter litoralis",5,"SER A 245;ILE A 208;TYR A 204;LEU A 205;LEU A 311","None","1.25A","3vn2A-4r39A:undetectable","3vn2A-4r39A:24.04"],["4F4D_B_CHDB503_0","FERROCHELATASE, MITOCHONDRIAL","4r39","BLUE-LIGHT-ACTIVATED HISTIDINE KINASE 2","Erythrobacter litoralis",4,"ILE A 151;ARG A 175;PRO A 294;TRP A 293","None;ANP A 402 (-3.8A);None;ANP A 402 (-4.4A)","1.26A","4f4dB-4r39A:undetectable","4f4dB-4r39A:21.45"],["4L1X_A_STRA402_1","ALDO-KETO REDUCTASE FAMILY 1 MEMBER C2","4r39","BLUE-LIGHT-ACTIVATED HISTIDINE KINASE 2","Erythrobacter litoralis",4,"TYR A 204;VAL A 278;LEU A 148;LEU A 307","None","1.02A","4l1xA-4r39A:undetectable","4l1xA-4r39A:22.40"],["4L1X_B_STRB402_1","ALDO-KETO REDUCTASE FAMILY 1 MEMBER C2","4r39","BLUE-LIGHT-ACTIVATED HISTIDINE KINASE 2","Erythrobacter litoralis",5,"TYR A 204;VAL A 278;ILE A 328;LEU A 148;LEU A 307","None","1.16A","4l1xB-4r39A:undetectable","4l1xB-4r39A:22.40"],["4URO_C_NOVC2000_1","DNA GYRASE SUBUNIT B","4r39","BLUE-LIGHT-ACTIVATED HISTIDINE KINASE 2","Erythrobacter litoralis",5,"ASP A 282;ARG A 285;ILE A 287;PRO A 288;ASP A 290","ANP A 402 (-2.7A);None;ANP A 402 (-4.3A);ANP A 402 ( 4.4A);None","1.29A","4uroC-4r39A:4.1","4uroC-4r39A:26.34"],["4URO_D_NOVD2000_1","DNA GYRASE SUBUNIT B","4r39","BLUE-LIGHT-ACTIVATED HISTIDINE KINASE 2","Erythrobacter litoralis",5,"ARG A 285;ILE A 287;PRO A 288;ASP A 290;THR A 324","None;ANP A 402 (-4.3A);ANP A 402 ( 4.4A);None;ANP A 402 (-3.6A)","1.17A","4uroD-4r39A:5.3","4uroD-4r39A:26.34"],["4URO_D_NOVD2000_1","DNA GYRASE SUBUNIT B","4r39","BLUE-LIGHT-ACTIVATED HISTIDINE KINASE 2","Erythrobacter litoralis",5,"ASN A 250;ARG A 285;ILE A 287;PRO A 288;THR A 324"," MG A 401 ( 2.4A);None;ANP A 402 (-4.3A);ANP A 402 ( 4.4A);ANP A 402 (-3.6A)","1.13A","4uroD-4r39A:5.3","4uroD-4r39A:26.34"],["4URO_D_NOVD2000_1","DNA GYRASE SUBUNIT B","4r39","BLUE-LIGHT-ACTIVATED HISTIDINE KINASE 2","Erythrobacter litoralis",5,"ASN A 250;ASP A 282;ILE A 287;PRO A 288;THR A 324"," MG A 401 ( 2.4A);ANP A 402 (-2.7A);ANP A 402 (-4.3A);ANP A 402 ( 4.4A);ANP A 402 (-3.6A)","0.90A","4uroD-4r39A:5.3","4uroD-4r39A:26.34"],["4URO_D_NOVD2000_1","DNA GYRASE SUBUNIT B","4r39","BLUE-LIGHT-ACTIVATED HISTIDINE KINASE 2","Erythrobacter litoralis",5,"ASP A 282;ILE A 287;PRO A 288;ASP A 290;THR A 324","ANP A 402 (-2.7A);ANP A 402 (-4.3A);ANP A 402 ( 4.4A);None;ANP A 402 (-3.6A)","0.88A","4uroD-4r39A:5.3","4uroD-4r39A:26.34"],["4YVP_B_GBMB402_1","ALDO-KETO REDUCTASE FAMILY 1 MEMBER C1","4r39","BLUE-LIGHT-ACTIVATED HISTIDINE KINASE 2","Erythrobacter litoralis",5,"TYR A 204;VAL A 278;ILE A 328;LEU A 148;LEU A 307","None","1.08A","4yvpB-4r39A:undetectable","4yvpB-4r39A:21.85"],["5DPD_A_SAMA601_0","PROTEIN LYSINE METHYLTRANSFERASE 1","4r39","BLUE-LIGHT-ACTIVATED HISTIDINE KINASE 2","Erythrobacter litoralis",5,"LEU A 332;SER A 333;GLN A 334;ILE A 240;VAL A 278","None","1.04A","5dpdA-4r39A:undetectable","5dpdA-4r39A:17.66"],["5DPD_B_SAMB601_0","PROTEIN LYSINE METHYLTRANSFERASE 1","4r39","BLUE-LIGHT-ACTIVATED HISTIDINE KINASE 2","Erythrobacter litoralis",5,"LEU A 332;SER A 333;GLN A 334;ILE A 240;VAL A 278","None","1.17A","5dpdB-4r39A:undetectable","5dpdB-4r39A:17.66"],["6DJZ_C_GMJC301_0","SIGMA NON-OPIOID INTRACELLULAR RECEPTOR 1","4r39","BLUE-LIGHT-ACTIVATED HISTIDINE KINASE 2","Erythrobacter litoralis",5,"LEU A 266;VAL A 308;THR A 249;LEU A 252;ALA A 251","None;None;None;None;ANP A 402 ( 4.1A)","1.15A","6djzC-4r39A:undetectable","6djzC-4r39A:24.44"],["6DLZ_A_CYZA1302_0","GLUTAMATE RECEPTOR 2,VOLTAGE-DEPENDENT CALCIUM CHANNEL GAMMA-2 SUBUNIT","4r39","BLUE-LIGHT-ACTIVATED HISTIDINE KINASE 2","Erythrobacter litoralis",5,"LEU A 242;SER A 245;ASP A 216;ILE A 303;GLY A 300","None;None;None;None;ANP A 402 (-3.3A)","1.46A","6dlzA-4r39A:undetectable;6dlzD-4r39A:undetectable","6dlzA-4r39A:17.04;6dlzD-4r39A:17.04"],["6DLZ_C_CYZC1302_0","GLUTAMATE RECEPTOR 2,VOLTAGE-DEPENDENT CALCIUM CHANNEL GAMMA-2 SUBUNIT","4r39","BLUE-LIGHT-ACTIVATED HISTIDINE KINASE 2","Erythrobacter litoralis",5,"ILE A 303;GLY A 300;LEU A 242;SER A 245;ASP A 216","None;ANP A 402 (-3.3A);None;None;None","1.46A","6dlzB-4r39A:undetectable;6dlzC-4r39A:undetectable","6dlzB-4r39A:17.04;6dlzC-4r39A:17.04"],["6DM1_A_CYZA1302_0","GLUTAMATE RECEPTOR 2,VOLTAGE-DEPENDENT CALCIUM CHANNEL GAMMA-2 SUBUNIT","4r39","BLUE-LIGHT-ACTIVATED HISTIDINE KINASE 2","Erythrobacter litoralis",5,"LEU A 242;SER A 245;ASP A 216;ILE A 303;GLY A 300","None;None;None;None;ANP A 402 (-3.3A)","1.46A","6dm1A-4r39A:undetectable;6dm1D-4r39A:undetectable","6dm1A-4r39A:17.04;6dm1D-4r39A:17.04"],["6DM1_C_CYZC1302_0","GLUTAMATE RECEPTOR 2,VOLTAGE-DEPENDENT CALCIUM CHANNEL GAMMA-2 SUBUNIT","4r39","BLUE-LIGHT-ACTIVATED HISTIDINE KINASE 2","Erythrobacter litoralis",5,"ILE A 303;GLY A 300;LEU A 242;SER A 245;ASP A 216","None;ANP A 402 (-3.3A);None;None;None","1.47A","6dm1B-4r39A:undetectable;6dm1C-4r39A:undetectable","6dm1B-4r39A:17.04;6dm1C-4r39A:17.04"]]